COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 2574: Articles 25731-25740  | Next

Numerical Analysis of Disastrous Effect of Reopening Too Soon in Georgia, USA
Basu, S.
10.1101/2020.07.01.20144667 — Posted: 2020-07-03
Retrospective Clinical Evaluation of Four Lateral Flow Assays for the Detection of SARS-CoV-2 Antibodies
McAulay, K., Bryan, A., Greninger, A. L., Grill, F., Lake, D. F., Kaleta, E. J., Grys, T. E.
10.1101/2020.07.01.20129882 — Posted: 2020-07-03
Association between angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers use and the risk of infection and clinical outcome of COVID-19: a comprehensive systematic review and meta-analysis.
Qu, G., Shu, L., Song, E. J., Verghese, D., Uy, J. P., Cheng, C., Zhou, Q., Yang, H., Guo, Z., Chen, M., Sun, C.
10.1101/2020.07.02.20144717 — Posted: 2020-07-03
Plasma IL-6 Levels following Corticosteroid Therapy as an Indicator of ICU Length of Stay in Critically ill COVID-19 Patients
Awasthi, S., Wagner, T., Venkatakrishnan, A., Puranik, A., Hurchik, M., Agarwal, V., Conrad, I., Kirkup, C., Arunachalam, R., O'Horo, J., Kremers, W., Kashyap, R., Morice, W., Halamka, J., Williams, A. W., Faubion, W. A., Badley, A. D., Gores, G. J., Soundararajan, V.
10.1101/2020.07.02.20144733 — Posted: 2020-07-03
Convalescent Plasma for COVID-19. A randomized clinical trial
Gharbharan, A., Jordans, C. C. E., GeurtsvanKessel, C., den Hollander, J. G., Karim, F., Mollema, F. P. N., Stalenhoef, J. E., Dofferhoff, A., Ludwig, I., Koster, A., Hassing, R.-J., Bos, J. C., van Pottelberge, G. R., Vlasveld, I. N., Ammerlaan, H. S. M., Segarceanu, E., Miedema, J., van der Eerden, M., Papageorgiou, G., te Broekhorst, P., Swaneveld, F. H., Katsikis, P. D., Mueller, Y., Okba, N. M. A., Koopmans, M. P. G., Haagmans, B. L., Rokx, C., Rijnders, B.
10.1101/2020.07.01.20139857 — Posted: 2020-07-03 Discussion: Onsite
HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa.
Western Cape Department of Health with National Institute for Communicable Diseases, South Africa, , Davies, M.-A.
10.1101/2020.07.02.20145185 — Posted: 2020-07-03
Disruption of the renal service during COVID-19 pandemic, physicians survey responses from 5 countries
Abdelaziz, T. S., Elsayed, E., Fathhy, M.
10.1101/2020.06.30.20143354 — Posted: 2020-07-03
Rapid detection of SARS-CoV-2 infection by multicapillary column coupled ion mobility spectrometry (MCC-IMS) of breath. A proof of concept study
Steppert, C., Steppert, I., Becher, G., Sterlacci, W., Bollinger, T.
10.1101/2020.06.30.20143347 — Posted: 2020-07-03
Bronchoscopy in critically ill COVID-19 Patients: microbiological profile and factors related to nosocomial respiratory infection
Serra Mitja, P., Centeno Clemente, C., Garcia-Olive, I., Antuori Torres, A., Casadella Fontdevila, M., Tazi Mezalek, R., Armestar, F., Fernandez Araujo, E., Andreo Garcia, F., Rosell Gratacos, A.
10.1101/2020.07.01.20144683 — Posted: 2020-07-03 Discussion: Onsite | Offsite
Non-Adherence Tree Analysis (NATA) - an adherence improvement framework: a COVID-19 case study
Edifor, E. E., Brown, R., Smith, P., Kossik, R.
10.1101/2020.06.30.20135343 — Posted: 2020-07-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).